Case 11-2010: A 69-year-old woman with lethargy, confusion, and abnormalities on brain imaging

New England Journal of Medicine

Volumn 362, Issue 15, 2010, Pages 1431-

  Venna, Nagagopal ^a,b   Gonzalez, R Gilberto ^a,b   Camelo Piragua, Sandra I ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CEFALEXIN; CORTICOSTEROID; DANAZOL; DOUBLE STRANDED DNA ANTIBODY; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; LA ANTIBODY; MIRTAZAPINE; NABUMETONE; PHOSPHOLIPID ANTIBODY; PREDNISONE; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; RITUXIMAB; RO ANTIBODY; ROFECOXIB; ROMIPLOSTIM; SM ANTIBODY;

AGED; APATHY; ARTICLE; BLOOD TRANSFUSION; BONE MARROW BIOPSY; CASE REPORT; CHILL; CLINICAL TRIAL; CONFUSION; CONNECTIVE TISSUE DISEASE; CORTICOSTEROID THERAPY; CYTOGENETICS; DAILY LIFE ACTIVITY; DRUG WITHDRAWAL; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL HEMORRHAGE; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LETHARGY; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS; MAJOR DEPRESSION; MEGAKARYOCYTE; MOTIVATION; NEUROIMAGING; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOSOCIAL WITHDRAWAL; SPLENECTOMY; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; THROMBOCYTE COUNT; TREATMENT RESPONSE; URINALYSIS; URINARY TRACT INFECTION; VISUAL HALLUCINATION; BRAIN; CLINICAL OBSERVATION; CLINICAL STUDY; DEPRESSION; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; IMMUNOCOMPROMISED PATIENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTION; PATHOLOGY; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;

ADRENAL CORTEX HORMONES; AGED; BRAIN; CONFUSION; CONNECTIVE TISSUE DISEASES; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; LETHARGY; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; OPPORTUNISTIC INFECTIONS;

EID: 77950966147     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc0910931     Document Type: Article

References (22)

1. Fong TG, Tulebaev SR, Inouye SK. Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol 2009;5:210-220
2. Sechi G, Serra A. Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management. Lancet Neurol 2007;6:442-455 (Pubitemid 46551868)
3. Meierkord H, Holtkamp M. Non-convulsive status epilepticus in adults: clinical forms and treatment. Lancet Neurol 2007;6:329-339 (Pubitemid 46367947)
4. Joseph FG, Lammie GA, Scolding NJ. CNS lupus: a study of 41 patients. Neurology 2007;69:644-654
5. Schiess N, Pardo CA. Hashimoto's encephalopathy. Ann N Y Acad Sci 2008;1142: 254-265
6. Cunha BA. Central nervous system infections in the compromised host: a diagnostic approach. Infect Dis Clin North Am 2001;15:567-590 (Pubitemid 32606914)
7. Seeley WW, Marty FM, Holmes TM, et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 2007;69:156-165
8. Case Records of the Massachusetts General Hospital (Case 39-2006). N Engl J Med 2006;355:2678-2689
9. Boren EJ, Cheema GS, Naguwa SM, Ansari AA, Gershwin ME. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases. J Autoimmun 2008;30:90-98
10. Calabrese LH, Molloy ES, Huang D, Ransohoff RM. Progressive multifocal leukoencephalopathy in rheumatic diseases: evolving clinical and pathologic patterns of disease. Arthritis Rheum 2007;56:2116-2128 (Pubitemid 47173558)
11. Carson KR, Evens AM, Richey EA, et al. Progressive multifocal leukoencephalopathy after rituximab therapy in HIVnegative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project. Blood 2009;113:4834-4840
12. Hunt MA, Jahnke K, Murillo TP, Neuwelt EA. Distinguishing primary central nervous system lymphoma from other central nervous system diseases: a neurosurgical perspective on diagnostic dilemmas and approaches. Neurosurg Focus 2006;21(5):E3.
13. Peretti-Viton P, Brunel H, Chinot O, et al. Histological and MR correlations in Gliomatosis cerebri. J Neurooncol 2002;59:249-259
14. Fong IW, Britton CB, Luinstra KE, Toma E, Mahony JB. Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy. J Clin Microbiol 1995;33:484-486
15. Cinque P, Bossolasco S, Brambilla AM, et al. The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature. J Neurovirol 2003;9:Suppl 1:73-80. (Pubitemid 36656475)
16. Vendrely A, Bienvenu B, Gasnault J, Thiebault JB, Salmon D, Gray F. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy. Acta Neuropathol 2005;109:449-455 (Pubitemid 40637320)
17. Khanna N, Elzi L, Mueller NJ, et al. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis 2009;48:1459-1466
18. Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004;306:1380-1383 (Pubitemid 39532516)
19. Brickelmaier M, Lugovskoy A, Kartikeyan R, et al. Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 2009;53:1840-1849
20. Aksamit AJ. Progressive multifocal leukoencephalopathy. Curr Treat Options Neurol 2008;10:178-185
21. Cettomai D, McArthur JC. Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy. Arch Neurol 2009;66:255-258
22. Kappos L, Bates D, Hartung HP, et al. Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol 2007;6:431-441 (Pubitemid 46551850)